Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07420582

Antegrade Autologous Blood Reinfusion After CPB

Conditions: Coronary Artery Disease

Sex: All
Ages: 18 Years – 80 Years
Healthy volunteers: No
Enrollment: 130
Sponsor: Kocaeli City Hospital

Location: Kocaeli City Hospital Kocaeli Izmit

Summary

This prospective observational study aims to evaluate the effect of antegrade pump blood reinfusion using the crystalloid "chase" technique on postoperative transfusion requirements in adult patients undergoing cardiac surgery with cardiopulmonary bypass. At the end of cardiopulmonary bypass, blood remaining within the cardiopulmonary bypass circuit is reinfused antegradely through the arterial line using a crystalloid chase, without collection or storage. Blood remaining within the bypass circuit after surgery represents a valuable source of autologous blood, and its reinfusion may contribute to perioperative blood conservation strategies. Patients receiving antegrade pump blood reinfusion via the chase technique will be compared with those managed without reinfusion, without any intervention by the investigators. The primary outcome is postoperative blood transfusion requirement.

Eligibility Criteria

Inclusion Criteria: * Age 18 to 80 years * Patients undergoing elective, isolated coronary artery bypass grafting surgery using cardiopulmonary bypass (on-pump). Exclusion Criteria: * Emergency or Redo cardiac surgery * Concomitant cardiac procedures (e.g., valve repair/replacement or aortic surgery). * Planned or intraoperative conversion to off-pump coronary artery bypass grafting * Preoperative hematocrit \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07420582). StuddyBuddy aggregates publicly available trial information.